4//SEC Filing
Miles Darrin 4
Accession 0001439222-21-000013
CIK 0001439222other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 4:14 PM ET
Size
11.9 KB
Accession
0001439222-21-000013
Insider Transaction Report
Form 4
Miles Darrin
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common stock
2021-02-14+8,666→ 14,541 total - Exercise/Conversion
Common stock
2021-02-16+922→ 15,463 total - Tax Payment
Common stock
2021-02-16−2,916→ 12,547 total - Exercise/Conversion
Restricted stock units
2021-02-16−922→ 0 total→ Common stock (922 underlying) - Exercise/Conversion
Restricted stock units
2021-02-14−8,666→ 17,334 total→ Common stock (8,666 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F2]The restricted stock units were granted on February 14, 2020. Beginning on February 14, 2021, the shares underlying the restricted stock units will vest in three equal annual installments.
- [F3]The restricted stock units were granted on February 16, 2018. Beginning on February 16, 2019, the shares underlying the restricted stock units vest in three equal annual installments.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001840076
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 4:14 PM ET
- Size
- 11.9 KB